INTERNATIONAL PATENT: WUXI BIOLOGICS (SHANGHAI) CO., LTD., WUXI BIOLOGICS IRELAND LIMITED FILES APPLICATION FOR "MULTISPECIFIC ANTIBODIES TARGETING CD3, CD19 AND CD20 AND USES THEREOF"

GENEVA, Aug. 4 -- WUXI BIOLOGICS (SHANGHAI) CO., LTD. (No. 299 Fute Zhong Road, Pudong New AreaShanghai 200131), WUXI BIOLOGICS IRELAND LIMITED (Mullagharlin, Dundalk, Co Louth A91 X56F) filed a patent application (PCT/CN2025/073620) for "MULTISPECIFIC ANTIBODIES TARGETING CD3, CD19 AND CD20 AND USES THEREOF" on Jan 21, 2025. With publication no. WO/2025/157132, the details related to the patent application was published on Jul 31, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FAN, Xinzhao (c/o No. 299 Fute Zhong Road, Pudong New AreaShanghai 200131), XU, Jianqing (c/o No. 299 Fute Zhong R...